On November 3, 2023, a Federal District Court issued a decision invalidating the Health Resources and Services Administration’s (HRSA’s) 340B “patient” definition. HRSA’s “patient” definition is key ...
On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a “patient” of a 340B program covered entity eligible to receive a 340B drug. In Genesis ...
The Health Resources and Services Administration’s definition of who qualifies as a patient under the 340B drug pricing program is too narrowly defined, a federal judge ruled Nov. 7. The lawsuit was ...